{
    "topic": "banking_and_finance",
    "source": "MarketWatch",
    "bias": 2,
    "url": "https://www.marketwatch.com/story/trumps-personal-stake-in-the-malaria-drug-maker-sanofi-could-be-as-small-as-99-2020-04-07",
    "title": "Trump\u2019s personal stake in the malaria-drug maker Sanofi could be as small as $99",
    "date": "2020-04-07",
    "authors": "Steve Goldstein",
    "content": "As President Donald Trump has persistently discussed the malaria drug hydroxychloroquine , critics have wondered about his motivation , given the drug \u2019 s far-from-certain performance on the global stage as a treatment for coronavirus , and the Food and Drug Administration \u2019 s refusal so far to approve it as a treatment for COVID-19 .\nThe New York Times says Trump has a \u201c small personal stake \u201d in Sanofi , the French drug manufacturer that produces the drug .\nThe report doesn \u2019 t say how small , but it notes that his three family trusts have investments in a Dodge & Cox mutual fund whose largest holding is Sanofi . A fund that matches this description is the Dodge & Cox International Stock Fund DODFX , +2.11 % , which at last check was 3.3 % invested in Sanofi .\nTrump \u2019 s 2019 financial-disclosure form lists stakes in Family Trusts 1 , 2 and 3 valued at between $ 1,001 and $ 15,000 . So if Trump has the maximum $ 15,000 in each of the trusts , he holds a stake in Sanofi that \u2019 s worth $ 1,485 \u2014 and , at the minimum , just $ 99 .\nIt turns out he does look to have more than that modest sum invested in Sanofi , because , unmentioned in the Times report , his trusts also hold broader European stock-market index funds .\nThe iShares Core MSCI EAFE ETF IEFA , +2.18 % has 0.67 % of its holdings in Sanofi , and Sanofi is a 0.78 % holding for the iShares MSCI EAFE ETF EFA , +2.26 % , which is neither surprising nor notable , in that the French drug maker is so large .\nAnd Trump has a small stake in basically every big company you can think of .\nIn each of the trusts , the biggest fund holding is just the broader SPDR S & P 500 ETF SPY , +1.52 % , in which Trump holds between $ 200,000 and $ 450,000 , according to his financial-disclosure forms .\nSo one could say Trump has $ 22,000 or so invested in Microsoft MSFT , +0.00 % , and nearly as much in Apple AAPL , +0.72 % .\nAnother point worth making is how little the malaria drug means to Sanofi \u2019 s bottom line . In 2019 , what the company calls Plaquenil wasn \u2019 t even broken out by name in the company \u2019 s financial accounts , while 33 other medications were .\nThat is hardly surprising as the drug has been around since the 1950s and is available generically .\nA host of other companies are making the medication , including Amneal Pharmaceuticals AMRX , +7.09 % , Mylan MYL , +6.20 % and Teva Pharmaceutical TEVA , +3.25 % .\nRead on : There \u2019 s scant evidence so far for chloroquine as a COVID-19 drug \u2014 but there \u2019 s already a shortage",
    "content_original": "As President Donald Trump has persistently discussed the malaria drug hydroxychloroquine, critics have wondered about his motivation, given the drug\u2019s far-from-certain performance on the global stage as a treatment for coronavirus, and the Food and Drug Administration\u2019s refusal so far to approve it as a treatment for COVID-19.\n\nThe New York Times says Trump has a \u201csmall personal stake\u201d in Sanofi, the French drug manufacturer that produces the drug.\n\nThe report doesn\u2019t say how small, but it notes that his three family trusts have investments in a Dodge & Cox mutual fund whose largest holding is Sanofi. A fund that matches this description is the Dodge & Cox International Stock Fund DODFX, +2.11% , which at last check was 3.3% invested in Sanofi.\n\nTrump\u2019s 2019 financial-disclosure form lists stakes in Family Trusts 1, 2 and 3 valued at between $1,001 and $15,000. So if Trump has the maximum $15,000 in each of the trusts, he holds a stake in Sanofi that\u2019s worth $1,485 \u2014 and, at the minimum, just $99.\n\nIt turns out he does look to have more than that modest sum invested in Sanofi, because, unmentioned in the Times report, his trusts also hold broader European stock-market index funds.\n\nThe iShares Core MSCI EAFE ETF IEFA, +2.18% has 0.67% of its holdings in Sanofi, and Sanofi is a 0.78% holding for the iShares MSCI EAFE ETF EFA, +2.26% , which is neither surprising nor notable, in that the French drug maker is so large.\n\nAnd Trump has a small stake in basically every big company you can think of.\n\nIn each of the trusts, the biggest fund holding is just the broader SPDR S&P 500 ETF SPY, +1.52% , in which Trump holds between $200,000 and $450,000, according to his financial-disclosure forms.\n\nSo one could say Trump has $22,000 or so invested in Microsoft MSFT, +0.00% , and nearly as much in Apple AAPL, +0.72% .\n\nAnother point worth making is how little the malaria drug means to Sanofi\u2019s bottom line. In 2019, what the company calls Plaquenil wasn\u2019t even broken out by name in the company\u2019s financial accounts, while 33 other medications were.\n\nThat is hardly surprising as the drug has been around since the 1950s and is available generically.\n\nA host of other companies are making the medication, including Amneal Pharmaceuticals AMRX, +7.09% , Mylan MYL, +6.20% and Teva Pharmaceutical TEVA, +3.25% .\n\nRead on:There\u2019s scant evidence so far for chloroquine as a COVID-19 drug \u2014 but there\u2019s already a shortage",
    "source_url": "www.marketwatch.com",
    "bias_text": "right",
    "ID": "ibxMxG6tWuQ7d7mQ"
}